DE122010000025I1 - Virale antigene - Google Patents

Virale antigene

Info

Publication number
DE122010000025I1
DE122010000025I1 DE122010000025C DE122010000025C DE122010000025I1 DE 122010000025 I1 DE122010000025 I1 DE 122010000025I1 DE 122010000025 C DE122010000025 C DE 122010000025C DE 122010000025 C DE122010000025 C DE 122010000025C DE 122010000025 I1 DE122010000025 I1 DE 122010000025I1
Authority
DE
Germany
Prior art keywords
antigene
viral
cell culture
directed
adherent cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE122010000025C
Other languages
German (de)
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter Healthcare SA
Original Assignee
Baxter Healthcare SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21723079&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE122010000025(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Healthcare SA filed Critical Baxter Healthcare SA
Publication of DE122010000025I1 publication Critical patent/DE122010000025I1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
DE122010000025C 2001-12-10 2002-12-10 Virale antigene Pending DE122010000025I1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/006,881 US6951752B2 (en) 2001-12-10 2001-12-10 Method for large scale production of virus antigen
PCT/EP2002/014011 WO2003054174A1 (en) 2001-12-10 2002-12-10 Method for large scale production of virus antigen

Publications (1)

Publication Number Publication Date
DE122010000025I1 true DE122010000025I1 (de) 2010-08-12

Family

ID=21723079

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60234211T Expired - Lifetime DE60234211D1 (de) 2001-12-10 2002-12-10 Verfahren zur produktion von viralen antigenen im grossmassstab
DE122010000025C Pending DE122010000025I1 (de) 2001-12-10 2002-12-10 Virale antigene

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE60234211T Expired - Lifetime DE60234211D1 (de) 2001-12-10 2002-12-10 Verfahren zur produktion von viralen antigenen im grossmassstab

Country Status (17)

Country Link
US (2) US6951752B2 (https=)
EP (3) EP2330189B1 (https=)
JP (2) JP4370511B2 (https=)
CN (2) CN101100657B (https=)
AT (1) ATE447010T2 (https=)
AU (1) AU2002358662B2 (https=)
CA (1) CA2469644C (https=)
DE (2) DE60234211D1 (https=)
DK (2) DK2330189T3 (https=)
ES (2) ES2488818T3 (https=)
FR (1) FR10C0026I1 (https=)
HU (1) HU225791B1 (https=)
MX (1) MXPA04005644A (https=)
NO (1) NO20042910L (https=)
PL (1) PL208232B1 (https=)
RU (1) RU2314344C2 (https=)
WO (1) WO2003054174A1 (https=)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7445924B2 (en) 2000-11-23 2008-11-04 Bavarian Nordic A/S Modified Vaccinia Ankara virus variant and cultivation method
US6951752B2 (en) * 2001-12-10 2005-10-04 Bexter Healthcare S.A. Method for large scale production of virus antigen
JP5322252B2 (ja) * 2001-12-20 2013-10-23 バヴァリアン・ノルディック・アクティーゼルスカブ 感染細胞からのポックスウイルスの採取および精製法
ES2305514T5 (es) 2002-09-05 2019-06-14 Bavarian Nordic As Método para la amplificación de un poxvirus en condiciones exentas de suero
MXPA05006523A (es) * 2002-12-23 2005-08-26 Squibb Bristol Myers Co Procesos de cultivo de celulas de mamiferos para la produccion de proteinas.
EP1697505A1 (en) * 2003-12-23 2006-09-06 Schering Corporation Methods for producing a549 cell lines stable in serum-free medium suspension culture
US20070207461A1 (en) 2004-02-23 2007-09-06 Crucell Holland B.V. Virus Purification Methods
JP4650798B2 (ja) * 2004-04-19 2011-03-16 デンカ生研株式会社 ウイルスの生産方法
JP2007537760A (ja) * 2004-05-20 2007-12-27 アイディー バイオメディカル コーポレイション インフルエンザワクチンを製造するためのプロセス
DK2368975T3 (en) 2004-12-23 2015-01-05 Medimmune Llc Non-tumorigenic MDCK cell line for the propagation of viruses
US7344839B2 (en) * 2004-12-23 2008-03-18 Aurx, Inc. Virus preparations and methods
CA2647985C (en) 2006-03-31 2014-12-30 Warf-Wisconsin Alumni Research Foundation High titer recombinant influenza viruses for vaccines
EP2615167A1 (en) 2006-09-15 2013-07-17 MedImmune, LLC Method for eliminating DNA contaminants from viral preparations
JP5084214B2 (ja) * 2006-09-29 2012-11-28 一般財団法人日本ポリオ研究所 Ｉｐｖワクチン
CN101688186A (zh) * 2007-05-04 2010-03-31 巴克斯特国际公司 用于病毒增殖的两阶段温度分布
US9474798B2 (en) 2007-06-18 2016-10-25 Wisconsin Alumni Research Foundation Influenza M2 protein mutant viruses as live influenza attenuated vaccines
CA2716801A1 (en) * 2008-03-12 2009-09-17 Wyeth Llc Methods for identifying cells suitable for large-scale production of recombinant proteins
US20110150926A1 (en) * 2008-08-01 2011-06-23 Mohammed Alsharifi Influenza vaccines
US8785173B2 (en) 2008-09-24 2014-07-22 Medimmune, Llc Methods for purification of viruses
EP2344634A4 (en) * 2008-09-24 2012-08-29 Medimmune Llc METHODS OF CELL CULTURE, AND PROPAGATION AND PURIFICATION OF VIRUSES
CA3150411C (en) 2009-07-31 2023-09-12 Pnuvax Inc. High yield yellow fever virus strain with increased propagation in cells
EP2493912B1 (en) 2009-10-26 2020-07-29 Wisconsin Alumni Research Foundation High titer recombinant influenza viruses with enhanced replication in vero cells
CN102782121A (zh) * 2009-12-23 2012-11-14 赛诺菲巴斯德有限公司 用于培养贴壁细胞的方法
US10130697B2 (en) 2010-03-23 2018-11-20 Wisconsin Alumni Research Foundation (Warf) Vaccines comprising mutant attenuated influenza viruses
BR112012026095A2 (pt) 2010-04-14 2015-09-15 Emd Millipore Corp métodos de produção de estoques de vírus de alta pureza e altos títulos e métodos de uso dos mesmos.
WO2012048276A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
CN101979517B (zh) * 2010-10-15 2011-12-28 普莱柯生物工程股份有限公司 一种利用生物反应器大规模生产流感病毒的方法
EP2667891B1 (en) 2011-01-27 2021-10-06 Gamma Vaccines Pty Limited Combination vaccines
JP2014527799A (ja) 2011-08-26 2014-10-23 ダブリュエーアールエフ−ウィスコンシン アラムナイ リサーチ ファウンデーション 変異型ｐｂ２遺伝子セグメントを有する弱毒化生ワクチンとしてのインフルエンザウイルス
CN102492659A (zh) * 2011-11-14 2012-06-13 成都康华生物制品有限公司 一种疫苗生产用甲肝病毒的生产方法
WO2015009743A1 (en) 2013-07-15 2015-01-22 Wisconsin Alumni Research Foundation High titer recombinant influenza viruses with enhanced replication in mdck or vero cells or eggs
CN103387958B (zh) * 2013-08-16 2016-04-06 北京科兴中维生物技术有限公司 人胚肺成纤维细胞sv-7在病毒培养中的应用
WO2015073913A1 (en) 2013-11-16 2015-05-21 Terumo Bct, Inc. Expanding cells in a bioreactor
WO2015148704A1 (en) 2014-03-25 2015-10-01 Terumo Bct, Inc. Passive replacement of media
US10053671B2 (en) 2014-06-20 2018-08-21 Wisconsin Alumni Research Foundation (Warf) Mutations that confer genetic stability to additional genes in influenza viruses
EP3198006B1 (en) 2014-09-26 2021-03-24 Terumo BCT, Inc. Scheduled feed
SG11201705866XA (en) 2015-01-26 2017-08-30 Ube Industries Method, device and kit for mass cultivation of cells using polyimide porous membrane
SG11201706066RA (en) 2015-01-26 2017-08-30 Ube Industries Method of producing substance
US10633422B2 (en) 2015-06-01 2020-04-28 Wisconsin Alumni Research Foundation (Warf) Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US9890363B2 (en) 2015-07-06 2018-02-13 Wisconsin Alumni Research Foundation (Warf) Influenza virus replication for vaccine development
US11197925B2 (en) 2016-02-19 2021-12-14 Wisconsin Alumni Research Foundation (Warf) Influenza B virus replication for vaccine development
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
EP3489342B1 (en) 2016-07-25 2022-01-26 UBE Industries, Ltd. Siphon type cultivation method
CA3031915A1 (en) 2016-07-25 2018-02-01 Ube Industries, Ltd. Cell culture module comprising a polymer porous film
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
CN117247899A (zh) 2017-03-31 2023-12-19 泰尔茂比司特公司 细胞扩增
WO2019084310A1 (en) 2017-10-25 2019-05-02 Yoshihiro Kawaoka HAS RECOMBINANT INFLUENZA VIRUSES STABILIZED FOR EGG REPLICATION
WO2019143291A1 (en) * 2018-01-18 2019-07-25 Yisheng Biopharma (Singapore) Pte. Ltd. Method for adapting influenza viruses to vero cells
US11911457B2 (en) 2018-02-07 2024-02-27 Bharat Biotech International Limited Process for enterovirus purification and inactivation and vaccine compositions obtained thereof
US12343390B2 (en) 2018-08-07 2025-07-01 Wisconsin Alumni Research Foundation (Warf) Recombinant biologically contained filovirus vaccine
JP7655849B2 (ja) 2018-08-20 2025-04-02 ウィスコンシン アルムニ リサーチ ファンデイション ヘマグルチニン（ｈａ）タンパク質内の非ドミナントエピトープに対する免疫応答を誘起するためのベクター
EP3914295A2 (en) 2019-01-23 2021-12-01 Yoshihiro Kawaoka Mutations that confer genetic stability to additional genes in influenza viruses
WO2020153619A1 (ko) * 2019-01-25 2020-07-30 바이로큐어 주식회사 Bhk-21 세포를 이용한 바이러스 생산방법
KR102228267B1 (ko) * 2019-01-25 2021-03-17 바이로큐어 주식회사 Bhk-21 세포를 이용한 바이러스 생산방법
EP3921413A1 (en) 2019-02-08 2021-12-15 Wisconsin Alumni Research Foundation (WARF) Humanized cell line
EP3924469A4 (en) * 2019-02-15 2022-12-14 Ology Bioservices, Inc. METHODS OF VIRUS PRODUCTION
CN114929269A (zh) 2019-05-01 2022-08-19 威斯康星校友研究基金会(Warf) 用于疫苗开发的改进的流感病毒复制
KR20220042117A (ko) 2019-08-09 2022-04-04 우베 고산 가부시키가이샤 엑소좀의 생성 방법
TW202122569A (zh) 2019-08-09 2021-06-16 日商宇部興產股份有限公司 應用小片多孔膜的細胞培養法
US11807872B2 (en) 2019-08-27 2023-11-07 Wisconsin Alumni Research Foundation (Warf) Recombinant influenza viruses with stabilized HA for replication in eggs
JP2023511444A (ja) 2020-01-24 2023-03-17 ウィスコンシン アルムニ リサーチ ファンデイション 安定化されたｎａを有する組換えインフルエンザウイルス
WO2021195410A1 (en) 2020-03-25 2021-09-30 Wisconsin Alumni Research Foundation (Warf) Recombinant multivalent influenza viruses
CN111850169B (zh) * 2020-07-16 2022-09-27 华农（肇庆）生物产业技术研究院有限公司 一种计算AIV在MDCK-sus细胞中细胞单位均产毒量的方法
EP4314244B1 (en) 2021-03-23 2025-07-23 Terumo BCT, Inc. Cell capture and expansion
US12209689B2 (en) 2022-02-28 2025-01-28 Terumo Kabushiki Kaisha Multiple-tube pinch valve assembly
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4525349A (en) 1981-12-29 1985-06-25 Societe Anonyme Dite: Institut Merueux Process for the large-scale production of a vaccine against poliomyelitis and the resulting vaccine
AT393356B (de) 1989-12-22 1991-10-10 Immuno Ag Verfahren zur herstellung von fsme-virus-antigen
US5719051A (en) * 1989-12-22 1998-02-17 Immuno Aktiengesellschaft Perfusion system and a method for the large scale production of virus or virus antigen
FR2723740B1 (fr) 1994-08-16 1996-11-08 Pasteur Merieux Serums Vacc Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications
US5824536A (en) * 1994-08-23 1998-10-20 St. Jude Children's Research Hospital Influenza virus replicated in mammalian cell culture and vaccine production
CA2205015C (en) 1994-11-10 2003-04-08 Otfried Kistner Method for producing biologicals in protein-free culture
DE19612966B4 (de) * 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
GB2319413B (en) * 1996-11-12 2001-06-06 Lsi Logic Corp Driver circuits
EP0981601B1 (en) * 1997-01-31 2006-09-06 Schering Corporation Methods for cultivating cells and propagating viruses
US6168944B1 (en) * 1997-01-31 2001-01-02 Schering Corporation Methods for cultivating cells and propagating viruses
AT407255B (de) 1997-06-20 2001-02-26 Immuno Ag Rekombinanter zellklon mit erhöhter stabilität in serum- und proteinfreiem medium und verfahren zur gewinnung des stabilen zellklons
US5994134A (en) * 1998-05-04 1999-11-30 Canji, Inc. Viral production process
US6855535B2 (en) * 2001-12-10 2005-02-15 Baxter Healthcare S.A. Method of large scale production of Hepatitis A virus
US6951752B2 (en) * 2001-12-10 2005-10-04 Bexter Healthcare S.A. Method for large scale production of virus antigen

Also Published As

Publication number Publication date
FR10C0026I1 (fr) 2011-01-14
DE60234211D1 (de) 2009-12-10
ES2335395T5 (es) 2017-08-31
DK2330189T3 (da) 2014-06-16
EP1453956B8 (en) 2010-02-10
HUP0402415A3 (en) 2005-07-28
ATE447010T2 (de) 2009-11-15
RU2314344C2 (ru) 2008-01-10
EP1453956B1 (en) 2009-10-28
EP1894998A8 (en) 2008-04-23
EP1453956A1 (en) 2004-09-08
JP2005512564A (ja) 2005-05-12
EP1894998A1 (en) 2008-03-05
PL373487A1 (en) 2005-09-05
CN101100657A (zh) 2008-01-09
JP5021000B2 (ja) 2012-09-05
RU2004121178A (ru) 2005-10-10
US20030108860A1 (en) 2003-06-12
HU225791B1 (en) 2007-09-28
EP2330189B1 (en) 2014-05-21
CA2469644C (en) 2013-07-23
NO20042910L (no) 2004-07-09
MXPA04005644A (es) 2005-04-19
AU2002358662B2 (en) 2008-05-15
AU2002358662A1 (en) 2003-07-09
CN1617924A (zh) 2005-05-18
HUP0402415A2 (hu) 2005-02-28
CA2469644A1 (en) 2003-07-03
DK1453956T3 (da) 2010-01-11
EP1453956B2 (en) 2017-01-18
PL208232B1 (pl) 2011-04-29
HK1115609A1 (en) 2008-12-05
EP2330189A1 (en) 2011-06-08
US20050181495A1 (en) 2005-08-18
US7524676B2 (en) 2009-04-28
WO2003054174A1 (en) 2003-07-03
ES2488818T3 (es) 2014-08-29
US6951752B2 (en) 2005-10-04
ES2335395T3 (es) 2010-03-26
CN101100657B (zh) 2012-05-30
JP4370511B2 (ja) 2009-11-25
JP2009261410A (ja) 2009-11-12
HK1158691A1 (en) 2012-07-20
CN100335619C (zh) 2007-09-05

Similar Documents

Publication Publication Date Title
DE122010000025I1 (de) Virale antigene
NZ333565A (en) Anticonvulsant topiramate derivatives useful in treating manic depressive bipolar disorder
WO2003067213A3 (en) Modulation of sulfate permease for photosynthetic hydrogen production
EP1629104A4 (en) CELL SURFACE EXPRESSION VECTOR OF SARS VIRUS ANTIGEN AND TRANSFORMED MICROORGANISMS
DE60028989D1 (de) Medium für die protein- und serumfreie zellkultur
HUP0105052A2 (hu) Eljárások nukleinsav amplifikálására és szekvenálására
ES2076944T3 (es) Procedimiento para el cultivo de bacterias.
DE60139429D1 (de) Pyrimidin-5-Onderivate als LDL-PLA2 Inhibitoren
ATE520769T1 (de) Enzymatische hydrolyse von biomassen mit hohem dm (dry matter)-gehalt
BR9910580B1 (pt) fermentador de estado sólido e procedimento para fermentação de estado sólido.
EP1480521A4 (en) MYELINIZATION OF CONGENITAL DYSMYELINIZED FRONTROOT WITH OLIGODIAN TROCYTE PRE-CREATOR CELLS
DE69901711D1 (de) Elektrode aus flexiblem graphitverbund
ATE526395T1 (de) Verwendung von il-7 und il-15 zur genetischen modifizierung von gedächtnis-t-lymphozyten
HK1048650A1 (zh) 在细胞培养物中增强细胞激动素(cytokines)的方法
TR199701762T1 (xx) Damar t�kanmas� tedavisi i�in azetidinon t�revleri.
ATE336567T1 (de) Zellkulturmedium
MXPA03008882A (es) Composiciones y metodos utiles para la infeccion por hcv.
DE60135312D1 (de) Methode zur herstellung hypermutierender bakterien
PL367306A1 (pl) Szczepionki na bazie autologicznych komórek T i sposoby ich otrzymywania
ATE530657T1 (de) Verfahren zur herstellung von zellinien mit latentem immunschwächevirus
ATE350484T1 (de) Test für mikroorganismen in zellkulturen
DE50103547D1 (de) Verwendung von sekundärem zellwandpolymer prokaryontischer mikroorganismen
DE60014120D1 (de) Herstellung von maleinsäureanhydrid
PT86552A (de) Gama-glutamyl-transpeptidase deren herstellung und deren verwendung
DE69434968D1 (de) Tiermodell für hepatitis-virus infektion